IBDEI2FS ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41328,1,4,0)
 ;;=4^C64.9
 ;;^UTILITY(U,$J,358.3,41328,2)
 ;;=^5001250
 ;;^UTILITY(U,$J,358.3,41329,0)
 ;;=C34.92^^159^2004^130
 ;;^UTILITY(U,$J,358.3,41329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41329,1,3,0)
 ;;=3^Malig Neop Left Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,41329,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,41329,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,41330,0)
 ;;=C34.90^^159^2004^116
 ;;^UTILITY(U,$J,358.3,41330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41330,1,3,0)
 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,41330,1,4,0)
 ;;=4^C34.90
 ;;^UTILITY(U,$J,358.3,41330,2)
 ;;=^5000966
 ;;^UTILITY(U,$J,358.3,41331,0)
 ;;=C65.9^^159^2004^150
 ;;^UTILITY(U,$J,358.3,41331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41331,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,41331,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,41331,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,41332,0)
 ;;=C50.912^^159^2004^131
 ;;^UTILITY(U,$J,358.3,41332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41332,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,41332,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,41332,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,41333,0)
 ;;=C50.911^^159^2004^153
 ;;^UTILITY(U,$J,358.3,41333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41333,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,41333,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,41333,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,41334,0)
 ;;=C50.919^^159^2004^123
 ;;^UTILITY(U,$J,358.3,41334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41334,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,41334,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,41334,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,41335,0)
 ;;=C62.90^^159^2004^161
 ;;^UTILITY(U,$J,358.3,41335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41335,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,41335,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,41335,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,41336,0)
 ;;=D03.9^^159^2004^165
 ;;^UTILITY(U,$J,358.3,41336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41336,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,41336,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,41336,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,41337,0)
 ;;=C45.0^^159^2004^166
 ;;^UTILITY(U,$J,358.3,41337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41337,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,41337,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,41337,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,41338,0)
 ;;=C90.01^^159^2004^168
 ;;^UTILITY(U,$J,358.3,41338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41338,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,41338,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,41338,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,41339,0)
 ;;=C90.00^^159^2004^169
 ;;^UTILITY(U,$J,358.3,41339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41339,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,41339,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,41339,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,41340,0)
 ;;=C94.6^^159^2004^170
 ;;^UTILITY(U,$J,358.3,41340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41340,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,41340,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,41340,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,41341,0)
 ;;=D61.82^^159^2004^171
 ;;^UTILITY(U,$J,358.3,41341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41341,1,3,0)
 ;;=3^Myelophthisis
